| RxseMel vs Reina | 70–54 | 56.45% |
| RxseMel vs Jin | 56–43 | 56.57% |
| RxseMel vs Bryan | 54–43 | 55.67% |
| RxseMel vs King | 60–32 | 65.22% |
| RxseMel vs Dragunov | 51–33 | 60.71% |
| RxseMel vs Kazuya | 45–36 | 55.56% |
| RxseMel vs Law | 30–44 | 40.54% |
| RxseMel vs Lars | 42–32 | 56.76% |
| RxseMel vs Clive | 33–41 | 44.59% |
| RxseMel vs Steve | 32–41 | 43.84% |
| RxseMel vs Lee | 32–40 | 44.44% |
| RxseMel vs Hwoarang | 36–32 | 52.94% |
| RxseMel vs Paul | 24–36 | 40.00% |
| RxseMel vs Lili | 32–27 | 54.24% |
| RxseMel vs Yoshimitsu | 21–32 | 39.62% |
| RxseMel vs Asuka | 24–27 | 47.06% |
| RxseMel vs Victor | 24–22 | 52.17% |
| RxseMel vs Azucena | 21–24 | 46.67% |
| RxseMel vs Xiaoyu | 19–21 | 47.50% |
| RxseMel vs Alisa | 18–21 | 46.15% |
| RxseMel vs Jack-8 | 19–15 | 55.88% |
| RxseMel vs Feng | 17–16 | 51.52% |
| RxseMel vs Nina | 20–9 | 68.97% |
| RxseMel vs Raven | 14–12 | 53.85% |
| RxseMel vs Lidia | 13–13 | 50.00% |
| RxseMel vs Jun | 12–13 | 48.00% |
| RxseMel vs Devil Jin | 7–16 | 30.43% |
| RxseMel vs Zafina | 11–11 | 50.00% |
| RxseMel vs Kuma | 13–8 | 61.90% |
| RxseMel vs Leo | 7–13 | 35.00% |
| RxseMel vs Eddy | 11–8 | 57.89% |
| RxseMel vs Leroy | 9–6 | 60.00% |
| RxseMel vs Claudio | 4–10 | 28.57% |
| RxseMel vs Shaheen | 4–7 | 36.36% |
| RxseMel vs Heihachi | 1–10 | 9.09% |
| RxseMel vs Panda | 0–4 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.